Zhou, H.; He, Z.; Wang, C.; Xie, T.; Liu, L.; Liu, C.; Song, F.; Ma, Y.
Intravenous Administration Is an Effective and Safe Route for Cancer Gene Therapy Using the Bifidobacterium-Mediated Recombinant HSV-1 Thymidine Kinase and Ganciclovir. Int. J. Mol. Sci. 2016, 17, 891.
https://doi.org/10.3390/ijms17060891
AMA Style
Zhou H, He Z, Wang C, Xie T, Liu L, Liu C, Song F, Ma Y.
Intravenous Administration Is an Effective and Safe Route for Cancer Gene Therapy Using the Bifidobacterium-Mediated Recombinant HSV-1 Thymidine Kinase and Ganciclovir. International Journal of Molecular Sciences. 2016; 17(6):891.
https://doi.org/10.3390/ijms17060891
Chicago/Turabian Style
Zhou, Huicong, Zhiliang He, Changdong Wang, Tingting Xie, Lin Liu, Chuanyang Liu, Fangzhou Song, and Yongping Ma.
2016. "Intravenous Administration Is an Effective and Safe Route for Cancer Gene Therapy Using the Bifidobacterium-Mediated Recombinant HSV-1 Thymidine Kinase and Ganciclovir" International Journal of Molecular Sciences 17, no. 6: 891.
https://doi.org/10.3390/ijms17060891
APA Style
Zhou, H., He, Z., Wang, C., Xie, T., Liu, L., Liu, C., Song, F., & Ma, Y.
(2016). Intravenous Administration Is an Effective and Safe Route for Cancer Gene Therapy Using the Bifidobacterium-Mediated Recombinant HSV-1 Thymidine Kinase and Ganciclovir. International Journal of Molecular Sciences, 17(6), 891.
https://doi.org/10.3390/ijms17060891